Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ASN002 Phase 1 SAD and Food Effect Study
NCT02853643Phase 1Completed
- Sponsor
- Asana BioSciences, LLC
- Start
- Jul 2016
- Primary completion
- Nov 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of gusacitinib in atopic dermatitis (AD) and chronic hand eczema (CHE) (3 arms), sponsored by Asana BioSciences, LLC. Primary endpoint: Number of subjects reporting adverse events. Started Jul 2016; status: completed.
02
Drugs
gusacitinib
03
Conditions
atopic dermatitis (AD)chronic hand eczema (CHE)
Beyond the preview
Go deeper on NCT02853643.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02853643.